Investing Profile

Igor DaCruz

InvestorVC
Managing Director, Life Sciences at Runway Growth Capital
Photo of Igor DaCruz, Managing Director at Runway Growth Capital
cb
Runway Growth Capital Managing Director
$10.0M - $50.0M
$25.0M
4
CompanyStageDateRound SizeTotal Raised
Neurolens
Series UnknownDec 2023$45M
$45M
SetPoint Medical
Debt FinancingJan 2023$65M
$300M
Co-investors: Josh Makower (New Enterprise Associates (NEA)), William Dai (ShangBay Capital), Hank Plain (Morgenthaler Ventures), Juan-Pablo Mas (Action Potential Venture Capital), Zack Scott (Norwest Venture Partners)
Revelle Aesthetics
Debt FinancingApr 2022$25M
$25M
Mustang Bio
Post Ipo DebtMar 2022$75M
$75M